Selected Publications:
Takeshita J, Eriksen W, Raziano V, Shah R, Bocage C, Gelfand JM, Barg F: Psoriasis Patients’ Perceptions of Therapies Differ by Race
J Invest Dermatol 138 (5S, Supplement 1): S46,2018.
Wan J, Oganisian A, Spieker A, Mitra N, Hoffstad O, Margolis D, Takeshita J: Racial Disparities in Medical Visits Among Children with Atopic Dermatitis in the Pediatric Eczema Elective Registry
J Invest Dermatol 138 (5S, Supplement 1): S52,2018.
Takeshita J, Shin DB, Ogdie A, Gelfand JM: Risk of Serious Infection, Opportunistic Infection and Herpes Zoster Among Patients With Psoriasis in the United Kingdom. Journal of Investigative Dermatology : 2018.
Fischer AH, Shin DB, Gelfand JM, Takeshita J: Health Care Utilization for Psoriasis in the United States Differs by Race: An Analysis of the 2001-2013 Medical Expenditures Panel Surveys.
Journal of the American Academy of Dermatology 78 (1): 200-203,2018.
Fischer AH, Shin DB, Margolis DJ, Takeshita J: Racial and Ethnic Differences in Health Care Utilization for Childhood Eczema: An Analysis of the 2001-2013 Medical Expenditures Panel Surveys
Journal of the American Academy of Dermatology 77 (6): 1060-1067,2017.
Takeshita, J., Gelfand, J.M., Li, P., Pinto, L., Yu, X., Rao, P., Viswanathan, H.N., Doshi, J.A.: Psoriasis in the U.S. Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use. J Invest Dermatol 135 (6): 1057-1065,2015.
Doshi, J.A., Takeshita, J., Pinto, L., Li, P., Yu, X., Rao, P., Viswanathan, H.N., Gelfand, J.M.: Factors Associated with Adherence, Discontinuation, Switching, and Restarting Biologic Therapy Among Psoriasis Patients in the U.S. Medicare Population. Journal of the American Academy of Dermatology 74 (6): 1057-1065,2016.
Takeshita, J., Wang, S., Shin, D.B., Mehta, N.N., Kimmel, S.E., Margolis, D.J., Troxel, A.B., Gelfand, J.M.: Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom. JAMA dermatology 151 (2): 161-9,2015.
Takeshita, J., Callis Duffin, K., Shin, D.B., Krueger, G.G., Robertson, A.D., Troxel, A.B., Van Voorhees, A.S., Gelfand, J.M.: Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting. Journal of the American Academy of Dermatology 71 (4): 633-41,2014.
Takeshita, J., Grewal, S., Langan, S.M., Mehta, N.N., Ogdie, A., Van Voorhees, A.S., Gelfand, J.M.: Psoriasis and Comorbid Diseases: Implications for Management. Journal of the American Academy of Dermatology 76 (3): 393,2017.
Takeshita, J., Grewal, S., Langan, S.M., Mehta, N.N., Ogdie, A., Van Voorhees, A.S., Gelfand, J.M.: Psoriasis and Comorbid Diseases: Epidemiology. Journal of the American Academy of Dermatology 76 (3): 377,2017.
Ogdie A, Harter L, Shin D, Baker J, Takeshita J, Choi HK, Love TJ, Gelfand JM.: The Risk of Fracture Among Patients with Psoriatic Arthritis and Psoriasis: A Population-Based Study.
Ann Rheum Dis 76 (5): 882,2017.
Grewal, S.K., Wan, J., Denburg, M.R., Shin, D.B., Takeshita, J., Gelfand, J.M.: The Risk of IgA Nephropathy and Glomerular Disease in Patients with Psoriasis: A Population-Based Cohort Study. Br J Dermatol 176 (5): 1366,2016.
Nelson, C.A., Takeshita, J., Wanat, K.A., Bream, K.D.W., Holms, J.H., Koenig, H.C., Roth, R.R., Vuppalapati, A., James, W.D., Kovarik, C.L.: Impact of Store-and-Forward Teledermatology on Outpatient Dermatologic Care: A Prospective Study in an Urban Underserved Primary Care Setting. Am Acad Dermatol 74 (3): 484-490.e1,2015.
Yeung, H., Takeshita, J., Mehta N.N., Kimmel, S.E., Ogdie, A., Margolis, D.J., Shin, D.B., Attor, R., Troxel, A.B., Gelfand, J.M.: Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatology 149 (10): 1173-9,2013.
Callis Duffin K, Yeung H, Takeshita J, Krueger G G, Robertson A D, Troxel A B, Shin D B, Van Voorhees A S, Gelfand J M: Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice. The British Journal of Dermatology 170 (3): 672-80,2014.
Takeshita, J., Mohler, E.R., Parasuram K., Moore, J., Rogers, W.T., Zhang, L., Gelfand, J.M., Mehta, N.N.: Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors. Journal of the American Heart Association 3 (1): e000507,2014.
Chung, J., Callis Duffin, K., Takeshita, J., Shin, D.B., Krueger, G.G., Robertson, A.D., Troxel, A.B., Van Voorhees, A.S., Edson-Heredia, E., Gelfand, J.M.: Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology 71 (4): 623-32,2014.
Takeshita, J., Wang, S., Shin, D.B., Callis Duffin, K., Krueger, G.G., Kalb, R.E., Weisman, J.D., Sperber, B.R., Stierstorfer, M.B., Brod, B.A., Schleicher, S.M., Robertson, A.D., Linn, K.A., Shinohara, R.T., Troxel, A.B., Van Voorhees, A.S., Gelfand, J.M.: Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting. Journal of the American Academy of Dermatology 71 (6): 1167-75,2014.